Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 480

1.

International standards for IgG and IgM anti-β2glycoprotein antibody measurement.

Willis R, Grossi C, Orietta Borghi M, Martos-Sevilla G, Zegers I, Sheldon J, Meroni P.

Lupus. 2014 Oct;23(12):1317-9. doi: 10.1177/0961203314544535.

PMID:
25228737
[PubMed - in process]
2.

Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells.

Borghi M, Raschi E, Grossi C, Chighizola C, Meroni P.

Lupus. 2014 Oct;23(12):1302-4. doi: 10.1177/0961203314536479.

PMID:
25228733
[PubMed - in process]
3.

New oral anticoagulants in thrombotic antiphospholipid syndrome.

Chighizola C, Moia M, Meroni P.

Lupus. 2014 Oct;23(12):1279-82. doi: 10.1177/0961203314540968.

PMID:
25228726
[PubMed - in process]
4.

Autoantibody profiling in APS.

Roggenbuck D, Somma V, Schierack P, Borghi M, Meroni P.

Lupus. 2014 Oct;23(12):1262-4. doi: 10.1177/0961203314534305.

PMID:
25228721
[PubMed - in process]
5.

Simultaneous Automated Screening and Confirmatory Testing for Vasculitis-Specific ANCA.

Sowa M, Grossmann K, Knütter I, Hiemann R, Röber N, Anderer U, Csernok E, Bogdanos DP, Borghi MO, Meroni PL, Schierack P, Reinhold D, Conrad K, Roggenbuck D.

PLoS One. 2014 Sep 16;9(9):e107743. doi: 10.1371/journal.pone.0107743. eCollection 2014.

PMID:
25225805
[PubMed - in process]
Free Article
6.

Safety considerations when prescribing immunosuppression medication to pregnant women.

Gerosa M, Meroni PL, Cimaz R.

Expert Opin Drug Saf. 2014 Sep 5:1-9. [Epub ahead of print]

PMID:
25189270
[PubMed - as supplied by publisher]
7.

Methotrexate for the treatment of rheumatoid arthritis in the biologic era: Still an "anchor" drug?

Favalli EG, Biggioggero M, Meroni PL.

Autoimmun Rev. 2014 Aug 26. pii: S1568-9972(14)00170-0. doi: 10.1016/j.autrev.2014.08.026. [Epub ahead of print] Review.

PMID:
25172238
[PubMed - as supplied by publisher]
8.

Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers.

Meroni PL, Chighizola CB, Rovelli F, Gerosa M.

Arthritis Res Ther. 2014;16(2):209.

PMID:
25166960
[PubMed - in process]
9.

High IL-17E and Low IL-17C Dermal Expression Identifies a Fibrosis-Specific Motif Common to Morphea and Systemic Sclerosis.

Lonati PA, Brembilla NC, Montanari E, Fontao L, Gabrielli A, Vettori S, Valentini G, Laffitte E, Kaya G, Meroni PL, Chizzolini C.

PLoS One. 2014 Aug 19;9(8):e105008. doi: 10.1371/journal.pone.0105008. eCollection 2014.

PMID:
25136988
[PubMed - in process]
Free PMC Article
10.

Autoantibodies in systemic autoimmune disorders.

Mahler M, Pierangeli S, Meroni PL, Fritzler MJ.

J Immunol Res. 2014;2014:263091. doi: 10.1155/2014/263091. Epub 2014 Jun 30. No abstract available.

PMID:
25097862
[PubMed - in process]
Free PMC Article
11.

Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study.

Ruffatti A, Salvan E, Del Ross T, Gerosa M, Andreoli L, Maina A, Alijotas-Reig J, De Carolis S, Mekinian A, Bertero MT, Canti V, Brucato A, Bremme K, Ramoni V, Mosca M, Di Poi E, Caramaschi P, Galeazzi M, Tincani A, Meroni PL.

Thromb Haemost. 2014 Jul 10;112(4). [Epub ahead of print]

PMID:
25008944
[PubMed - as supplied by publisher]
12.

Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome.

Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, Meroni PL, Cugno M.

Clin Exp Immunol. 2014 Oct;178(1):48-56. doi: 10.1111/cei.12394.

PMID:
24903614
[PubMed - in process]
13.

Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Mahler M, Meroni PL, Bossuyt X, Fritzler MJ.

J Immunol Res. 2014;2014:315179. doi: 10.1155/2014/315179. Epub 2014 Apr 27. Review.

PMID:
24868563
[PubMed - in process]
Free PMC Article
14.

14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends.

Bertolaccini ML, Amengual O, Andreoli L, Atsumi T, Chighizola CB, Forastiero R, de Groot P, Lakos G, Lambert M, Meroni P, Ortel TL, Petri M, Rahman A, Roubey R, Sciascia S, Snyder M, Tebo AE, Tincani A, Willis R.

Autoimmun Rev. 2014 May 10. pii: S1568-9972(14)00120-7. doi: 10.1016/j.autrev.2014.05.001. [Epub ahead of print] Review.

PMID:
24824074
[PubMed - as supplied by publisher]
15.

Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder.

D'Ippolito S, Meroni PL, Koike T, Veglia M, Scambia G, Di Simone N.

Autoimmun Rev. 2014 May 10. pii: S1568-9972(14)00123-2. doi: 10.1016/j.autrev.2014.05.004. [Epub ahead of print] Review.

PMID:
24820522
[PubMed - as supplied by publisher]
16.

Survival on treatment with second-line biologic therapy: a cohort study comparing cycling and swap strategies.

Favalli EG, Biggioggero M, Marchesoni A, Meroni PL.

Rheumatology (Oxford). 2014 Sep;53(9):1664-8. doi: 10.1093/rheumatology/keu158. Epub 2014 Apr 12.

PMID:
24729445
[PubMed - in process]
17.

Drug survival and reasons for discontinuation of the first course of biological therapy in 301 juvenile idiopathic arthritis patients.

Romano M, Pontikaki I, Gattinara M, Ardoino I, Donati C, Boracchi P, Meroni PL, Gerloni V.

Reumatismo. 2014 Mar 17;65(6):278-85. doi: 10.4081/reumatismo.2013.682.

PMID:
24705031
[PubMed - in process]
18.

Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.

Mangano K, Fagone P, Bendtzen K, Meroni PL, Quattrocchi C, Mammana S, Di Rosa M, Malaguarnera L, Coco M, Magro G, Di Marco R, Nicoletti F.

J Cell Physiol. 2014 Dec;229(12):1918-25. doi: 10.1002/jcp.24641.

PMID:
24700487
[PubMed - in process]
19.

Tumour Necrosis Factor α Antagonists in the Treatment of Rheumatoid Arthritis: An Immunological Perspective.

Meroni PL, Valesini G.

BioDrugs. 2014 Apr;28 Suppl 1:5-13. doi: 10.1007/s40259-013-0063-0.

PMID:
24687234
[PubMed - in process]
20.

β2-glycoprotein I, lipopolysaccharide and endothelial TLR4: Three players in the two hit theory for anti-phospholipid-mediated thrombosis.

Raschi E, Chighizola CB, Grossi C, Ronda N, Gatti R, Meroni PL, Borghi MO.

J Autoimmun. 2014 Mar 27. pii: S0896-8411(14)00065-1. doi: 10.1016/j.jaut.2014.03.001. [Epub ahead of print]

PMID:
24685231
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk